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Abstract
Background: Complementary and Alternative Medicine (CAM) is increasingly popular with cancer patients and yet
information provision or discussion about CAM by health professionals remains low. Previous research suggests that
patients may fear clinicians' 'disapproval' if they raise the subject of CAM, and turn to other sources to acquire
information about CAM. However, little empirical research has been conducted into how cancer patients acquire, and,
more importantly evaluate CAM information before deciding which CAM therapies to try.
Methods: Qualitative study, comprising semi-structured interviews with 43 male cancer patients of varying ages, cancer
type and stage of illness, 34 of whom had used CAM. They were recruited from a range of NHS and non-NHS settings
in Bristol, England.
Results: As a result of the lack of CAM information from health professionals, men in this study became either 'pro-
active seekers' or 'passive recipients' of such information. Their main information resource was the 'lay referral' network
of family, friends and acquaintances, especially females. 'Traditional' information sources, including books, magazines,
leaflets and the media were popular, more so in fact than the internet. Views on the internet ranged from enthusiasm or
healthy scepticism through to caution or disinterest. CAM information was generally regarded as 'empowering' as it
broadened treatment and self-care options. A minority of participants were information averse fearing additional choices
that might disrupt their fragile ability to cope. There was general consensus that CAM information should be available
via the NHS, to give it a 'stamp of approval', which combined with guidance from informed health professionals, could
help patients to make 'guided' choices. However, a small minority of these men valued the independence of CAM from
the NHS and deliberately sought 'alternative' information sources and treatment options.
Men were selective in identifying particular therapies to use and sceptical about others, basing their choices on forms of
'evidence' that were personally meaningful: personal stories of individuals who had been helped by CAM; the long history
and enduring popularity of some therapies; the plausibility of the mechanism of action; a belief or trust in individual
therapies or their providers; scientific evidence. Scientific evidence ranked low in the men's personal decision-making
about CAM, while it was recognised as important for NHS support for CAM.
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Conclusion: These male cancer patients valued the support and guidance of 'trusted individuals' in making choices about
CAM. Trusted health professionals could also play a significant role in helping patients to make informed choices. Any
such dialogue must, however, acknowledge the different standards of evidence used by patients and clinicians to evaluate
the benefits or otherwise of CAM therapies. Such open communication could help to foster an environment of mutual
trust where patients are encouraged to discuss their interest in CAM, rather than perpetuate covert, undisclosed use of
CAM with its attendant potential hazards.
Background
The increasing use of complementary and alternative
medicine (CAM) by cancer patients has been well docu-
mented [1,2] and yet the reported level of disclosure to
medical practitioners (33% – 60%) remains of concern, in
view of the risk of potentially harmful pharmacological
interactions [3]. A culture of 'pervasive silence' and 'pro-
fessional disinterest' has been described in relation to
CAM, so patients may be reluctant to raise the subject in
case health professionals 'disapprove' [4]. Clinicians and
nurses are rarely cited as a source of information about
CAM [2], leaving the field wide open for patients to
explore other, potentially less reliable, avenues. For exam-
ple, much has been written about the increasing popular-
ity of the internet as a source of health information [5],
allowing unregulated access to 'unproven' and potentially
harmful treatments [6]. Little empirical research has been
conducted, however, on what sources of CAM informa-
tion cancer patients actually use. Some studies have sug-
gested that, despite the advent of the internet, 'traditional
sources' of information are still important to cancer
patients seeking disease-related information [7] and that
preferences for different forms of information may be
related to ethnicity and educational level [8]. With regards
to internet use, one author found that patients displayed
'considerable caution and competence' in handling infor-
mation about their condition obtained in this way [9]. We
do not know whether the same applies to patients' han-
dling of information about CAM therapies.
There is also little understanding of how CAM informa-
tion is used and evaluated by patients in their decisions
whether to try CAM and which therapies to use. Patients
may be using evidence based on very different notions of
'therapeutic efficacy' compared to clinicians [10].
Research suggests that patients tend to use 'anecdotal'
rather than 'scientific' evidence and this may impact on
the ability of professionals and patients to 'develop a dia-
logue about CAM decision making' [11].
This study focuses on use and evaluation of CAM related
information by male cancer patients. It draws on qualita-
tive data from a larger study of male cancer patients' atti-
tudes towards and use of CAM. Previous studies have
shown that male cancer patients tend to request support
and information about their condition less than women,
both within consultations and from other sources
[12,13]. Thus it is important to investigate what sources of
information are preferred by men, and whether, in fact,
the reported popularity of the internet has impacted on
their knowledge about CAM. This paper focuses particu-
larly on how male cancer patients obtain, evaluate and use
CAM information, drawing out some implications for
information provision and patient-professional commu-
nication.
Methods
A qualitative research design was used in order to explore
the processes involved in gathering and evaluating infor-
mation about CAM from the perspective of men with can-
cer. Ethical approval was gained from the local NHS
Research Ethics Committee.
Participants
Purposeful sampling [14] was used with a recruitment
strategy aimed at maximum variation with regards to age,
cancer type, stage of illness and potential attitudes
towards CAM. In order to identify men who potentially
held a range of views about CAM, they were recruited
from three contrasting settings: an NHS oncology centre
(where CAM users were identified in outpatient clinics
using a short screening questionnaire), the outpatients
clinics at a NHS homeopathic hospital and a cancer char-
ity providing CAM therapies paid for privately. A small
sub-sample of patients who had never used CAM was also
recruited.
Data collection
Semi-structured interviews were carried out with partici-
pants in their own homes, covering a range of topics relat-
ing to their use of CAM. The topics reported here include:
how information on CAM was obtained; which sources of
information were most useful; how this information was
used in decisions about using CAM. Interviews were
recorded and fully transcribed and the data were analysed
thematically, drawing on the principles of constant com-
parison [15].
Data analysis
ME took the lead in coding and analysing the data, aided
by the qualitative analysis software Atlas.ti. AS read and
coded a sub-set of the interview transcripts from eachBMC Complementary and Alternative Medicine 2007, 7:25 http://www.biomedcentral.com/1472-6882/7/25
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recruitment setting, and met with ME to discuss the devel-
oping coding framework and agree on broad themes.
Members of the steering group also read sections of some
transcripts and commented on the coding framework.
Results
Participants
The study comprised thirty-four male cancer patients who
were using CAM, evenly distributed across the treatment
sites: eleven from the oncology unit, twelve from the
homeopathic hospital and eleven from the cancer charity.
A broad spectrum was achieved across the sampling crite-
ria. The age of participants ranged from 31 to 83 years,
with a mean of 57 years. The spread across cancer type and
stage of illness is shown in Tables 1 and 2. Participants
were white and came from a range of manual, non-man-
ual and professional occupational backgrounds. Over half
were professional. Twenty-two participants had used
CAM before their cancer diagnosis, for other health prob-
lems or for health maintenance, while for twelve partici-
pants, cancer had been the trigger to CAM use. Seven 'non-
users of CAM' were also interviewed and they cited lack of
knowledge and information about CAM as major reasons
for non-use. Some non-users were sceptical about CAM
but felt that CAM information and advice should be more
readily available through the NHS.
This paper will focus on those men who were using CAM.
The types of CAM used by the men are shown in Appendix
1. All participants used CAM alongside their conventional
treatment, except for one man who had refused orthodox
treatment in favour of CAM therapies. The ways in which
CAM was used and the perceived benefits are reported
elsewhere [16]. The focus of this paper is how the men
sought, evaluated and used CAM information. Data illus-
trating each theme are mostly provided in tables 4 to 9,
with some quotes illustrating key points interspersed
within the text.
Information resources used
Men talked about the lack of CAM information available
from the NHS and the difficulty in engaging in discussion
about CAM with professionals they encountered during
their conventional care (see Appendix 2). One man, who
went on to access support from the CAM charity,
described his frustration and sadness. 'I asked my oncol-
ogy doctor are there any other avenues and the response
was well there are one or two things but nothing has been
proven and there's nothing very definite ... and I suppose
that's what's I suppose is very sad ... I chose not to probe
... you can detect there is no inclination, no desire, no
WANT to debate it or discuss it ... you get this very clear
message'  [age 64, oesophageal cancer in palliative care].
Another participant talked about the possibility of
empowering patients by making CAM information acces-
sible. 'I just think that information should be out there for
people to make decisions and to let them know that it's
there because even just on a pain level, because there's
there are therapies out there which can help people with
their pain management and if you can manage your pain
that helps your process so much' [age 32, recurrent bone
cancer].
The main resource for these men was the 'lay referral net-
work' [17]: personal stories and recommendations passed
on by family, friends, work colleagues and other acquaint-
ances, often provoked by a cancer diagnosis. Some
responded to advertisements in local shops. Female fam-
ily members played a significant role in steering men
towards CAM, especially wives and daughters who had
knowledge or personal experience of CAM (see Appendix
3). For example, this man reflected on the important role
his daughter had played. 'I was lucky with my daughter ....
How I would have done without her .... because she's been
a nutritionalist for some time .... she's always been a
health enthusiast but she's a realist, she believes in really
a healthy diet and she doesn't mean filling you up with
vitamins' [age 74, colo-rectal cancer in remission].
The internet was rarely the first port-of-call for CAM infor-
mation (see Appendix 4); in fact it was used more often to
research conventional rather than CAM treatments. With
regards to CAM, the internet provided the means to inves-
tigate a CAM therapy mentioned by an acquaintance, to
order books or nutritional supplements or to find a CAM
therapist via a professional organisation. Those who used
the internet described how they were selective in their
choice of web-sites, rather than pursuing general searches,
Table 2: Stage of disease





Table 1: Cancer type




Other (thymic, tonsillar, 
pancreatic, bone, lymphoma, 
bladder, renal, oesophageal, 
leukaemia)
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as illustrated by this man, who stopped searching 'once I
found the charity web-site ...which was very good because
a lot of the people who were there have had the disease
and a lot of the information is from people who've been
through the same thing' [age 54, prostate cancer in remis-
sion].
A surprising proportion of the men lacked either the expe-
rience or the inclination to engage in internet searching
and this was true across all ages. 'No I have not [used the
internet] ... I have looked I mean there are dangers there I
mean quite apart from all the trash that comes in trying to
sell us Viagra and all sorts of things .... So no no I have not,
I am very happy to take the advice and treatment offered
by [holistic doctor] for example and the acupuncture as
well!' [age 73, prostate cancer in remission]
Some of the older participants described how searches
had been performed on their behalf by family members,
such as this man: 'The internet, my wife's a bit of a dab
hand on the internet and that, she's got an awful lot of
information ... there's so much of it on there you know it
sort of gives you some sort of hope when everything seems
lost....
Q: Have you actually ordered anything over the internet?
No ... oh well the bush telegraph I mean is better than the
internet really' [age 60, locally advanced lung cancer].
'Traditional' sources of information such as books, leaflets
and the media were generally more popular than the
internet (see Appendix 5). For example men responded to
written information in the form of booklets provided by
charities, Yellow Pages and mailshots. 'How I chose the
ones [types of CAM] that I'm pursuing I went by this little
book particularly to start with, having read the cancer
BACUP book which listed them and a paragraph or two
about each one .. and this book, the 'Which Guide to
Complementary Therapies', I think I bought it from
Waterstone's or somewhere like that ... and 'The Web that
has no weaver' it's an attempt in some ways to reconcile
Chinese and Western medicine' [age 65, metastatic colo-rec-
tal cancer].
Stories about CAM and its proponents were frequently
found on television and radio or read in newspapers and
magazines. Books recounting stories of survival from can-
cer, or advocating anti-cancer diets and CAM therapies
were passed around the 'lay network'. 'The friend from
Australia sent me some tapes, meditation, visualisation
tapes and a book by I.G. who's beat cancer in his own way,
and I'm just interested to read his story, so I started off lis-
tening to these tapes and realising there's something in
this, so I thought I need to go a little bit more in that direc-
tion so I went to the [private cancer charity]' [age 49, met-
astatic colo-rectal cancer].
Two key themes regarding information use emerged in the
analysis. Data such as these, that are based on personal
experiences, serve as an illustration of how a group of
patients navigated their way through the CAM informa-
tion available, some of which has been referred to as 'mis-
leading' and potentially 'harmful' [6]. The two main
themes are as follows: First we will consider the role
patients take in information seeking – whether they are
pro-active seekers or passive recipients of CAM informa-
tion. Second we will consider the types of evidence and
criteria that patients use to evaluate CAM. The themes pre-
sented are supported by data reflecting the full range of
expressed views (see Appendices 6 and 7).
Theme 1: Patients as pro-active seekers or passive 
recipients of CAM information
A willingness on the part of these men to be informed
about CAM was linked to their desire to know as much as
possible about their illness generally, including their con-
ventional treatment options. Participants could be
broadly categorised into those who actively sought out
information about CAM (pro-active seekers) and those
who took a more passive stance and simply picked up
information that came their way (passive recipients) (see
Appendix 6). Which role they took depended partly on
their cancer type and stage of illness. Pro-active informa-
tion seekers were often men with more rare cancers, fast-
growing tumours or advanced disease. For these men,
information about CAM included seeking out 'alternative'
and potentially 'curative' treatments, especially if conven-
tional treatments could no longer help them. Some men
who were at earlier stages of illness or who had more com-
mon types of cancer, also took a pro-active approach but
they more commonly searched for information about
supportive or complementary treatments to be used
alongside their conventional treatment.
Men's role in information gathering also related to the
stage at which they had started using CAM. The men in
this study fell into two broad groups: those who had used
CAM prior to their cancer (the majority) and those for
whom a cancer diagnosis was the trigger to CAM use.
Those characterised as pro-active seekers of CAM were
more likely to have already used CAM before their cancer
diagnosis than to be 'new' users. 'Pro-active seekers'
tended to embrace a wider range of therapies than those
who were 'passive recipients' of information.
Those who could be characterised as 'passive recipients' of
CAM information (just over one third of the participants)
were equally divided between those who had used CAM
for previous health problems and those who were 'new'BMC Complementary and Alternative Medicine 2007, 7:25 http://www.biomedcentral.com/1472-6882/7/25
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users following their cancer diagnosis. CAM information
was generally welcomed and acted upon, even if it was
treated initially with scepticism. Passive recipients were
(perhaps unsurprisingly) more likely to be drawn from
the NHS recruitment sites rather than the private setting,
and a few had in fact first heard about CAM from an NHS
health professional, albeit in a very general way. They
recounted how CAM therapies were sometimes suggested
by a doctor or nurse in primary care, both prior to and
since the cancer diagnosis: for example, a recommenda-
tion to try chiropractic for a back problem or homeopathy
for cancer-related symptoms. Within oncology services,
however, CAM was mentioned only occasionally in a
non-specific way as a possible support for end-stage
patients, but with no specific recommendations. As a
result of these suggestions, in combination with encour-
agement by family members who had some experience or
knowledge of CAM, some men were triggered into CAM
use. However, in contrast to the pro-active information
seekers who embraced a wide range of therapies, those
with a more passive role in acquiring information tended
to use only the therapy that they first encountered, for
example taking nutritional supplements or attending the
homeopathic hospital.
Satisfaction with information-seeking role
Participants reflected on their role in information gather-
ing, some feeling that they had taken on either a pro-
active or a passive role by choice, but others noting how
they took up their position rather by default, because they
felt it was their only option. For example, some described
how the passive role sometimes arose as a result of the
lack of open discussion about CAM within the NHS and
the difficulty they experienced in raising the subject. Some
speculated as to whether oncologists' reluctance to engage
with the topic was driven by individual disinterest or scep-
ticism, or by hospital policy.
Others, however, responded to the lack of CAM informa-
tion available from NHS health professionals by taking on
a pro-active information-seeking role. 'He [oncologist]
was a bit offhand, wasn't really ready to give me much
information, I had to sort of, you know, pump him shall
we say .... I got the information out of him but it was a
question of sort of pulling teeth if you like, if you didn't
ask the question you didn't get told was the impression I
got' [age 52, localised prostate cancer]. Some willingly took
on this role, whereas others found it difficult on several
counts. First: they found it difficult to formulate questions
about CAM within consultations, not knowing what or
who to ask and what clinicians' reactions would be. Sec-
ond: they were reluctant to go outside of conventional
medicine to seek information and support regarding
CAM, having the hope and expectation that CAM infor-
mation would be more easily available within the NHS
and expressing disappointment when it was not. Third:
they wanted a stamp of approval from NHS professionals
regarding the CAM therapies they chose to use, preferring
those that would be seen as medically 'legitimate'.
As a minimum, many of the men felt that NHS profes-
sionals should adopt a 'sign-posting' role, even if they did
not provide detailed information on CAM, for example by
providing a list of CAM information resources and practi-
tioners. Amongst the pro-active information seekers there
was also a minority who preferred to look outside the
NHS for CAM information and were seeking 'alternative'
approaches to their illness and its treatment.
Information as empowering or anxiety provoking
Whether men took a 'pro-active' or 'passive' approach to
gathering CAM information may partly be explained by
their underlying general attitude towards information
about their condition. 'Pro-active' seekers generally
regarded information as a tool for empowerment,
whereas the more 'passive' approach was typical of men
who perceived information as potentially unsettling or
anxiety provoking. 'Empowerment' was experienced as
getting a better understanding of the illness and its treat-
ment that enabled participants to make informed contri-
butions to treatment decisions or to engage in self-care. 'I
said thank you very much that's great and I've been really
wanting this information, I'm not ready for an operation
yet, I feel good, I'm not ready for one, I'm thinking of
moving and he was a bit put out at that, this person, given
all this information, and he doesn't want, he said well OK
he said I really advise that we should operate as soon as
possible before it gets too big' [age 43, recurrent bone can-
cer].
Some wanted very detailed information such as survival
statistics, personal prognosis, tumour grading, details of
surgical procedures or wished to view their scans. They
also sought information about psycho-social support, to
help them deal with either living or dying with their dis-
ease. CAM information in particular was perceived as
'empowering' as it led to opportunities for self-care and
gave feelings of control and hope in a potentially fearful
and life-threatening situation. Such information broad-
ened their treatment and supportive care options in ways
that they weren't routinely getting in their NHS care. For
many, finding out about CAM was a strategy to fill per-
ceived gaps in their conventional care [16].
Amongst the 'passive recipients' of information were
some who were wary of finding out too much about their
condition for fear that the information would bring with
it added anxiety, responsibility and stress, with further
decisions to be made. They had clear boundaries around
what they wanted to know and reported feeling over-BMC Complementary and Alternative Medicine 2007, 7:25 http://www.biomedcentral.com/1472-6882/7/25
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whelmed if confronted with 'too much' information. They
viewed information as 'unsettling' with the potential to
disrupt their fragile ability to cope and they preferred to
focus on what lay immediately ahead of them. Informa-
tion brought to them by well-wishers could be seen as an
unwelcome intrusion. 'The worst for me was people
bringing me sheets of paper [from the internet] at work
and you read them and think I'm not going to go through
that and there was so much ... trouble is you read 'Cancer'
and all you read about is people dying, the local paper are
doing a series about it, one in four people getting over it,
four out of ten are going to die and that's what the internet
is it's instantly that you go in and you think you're better
off getting treated in Australia or there's America, and its
pages long' [age 54, prostate cancer in remission].
Changes in information-seeking role
The boundaries between the categories of 'passive recipi-
ent' and 'pro-active seeker' were inevitably fluid and there
was evidence of change over time as men's interest in
CAM grew and their approach to acquiring information
evolved over time. Some of those who were initially 'pas-
sive recipients' of CAM information shifted roles to
become 'pro-active seekers' as they acquired information
about CAM and developed an interest in finding out
more. Some men who were initially sceptical about CAM
changed their views and adopted CAM as part of their
overall treatment and support strategy. They described a
growing awareness of stories and issues relevant to cancer
and its treatment (both conventional and CAM) as they
lived with their condition. Others found their interest in
CAM initially stimulated by the chance reading of a mag-
azine article or an inspirational book lent by a friend
which then triggered them into a more active role in find-
ing out about CAM.
Once men started actively seeking CAM information, a
process of 'snowballing' took over as networks of
resources were uncovered. 'A lot of books, research on the
internet, all kinds of articles, as soon as you've got cancer
you come across other people who know about other peo-
ple and relatives and the like who've been through it all
and they say oh have you seen this book, seen this article,
look at that website, you end up with a mountain of infor-
mation' [age 51, tonsillar cancer palliative care].
Theme 2: Types of evidence: patients' criteria for 
evaluating CAM information and therapies
Patients used a variety of forms of 'evidence' to make
judgements about CAM and whether they would use a
particular therapy. Rather than a wholesale acceptance of
all types of CAM, the men in this study described how
they attempted to be discerning in evaluating the informa-
tion available, in order to choose the type of CAM that
might suit them. They were usually very selective in iden-
tifying a particular CAM for a particular problem and were
often sceptical about other therapies. For example many
men were wary about any form of therapy that involved
participation in a group, one man expressing this as dis-
taste for 'hand-holding and all that sort of thing'. Within
the array of information available to them, patients
tended to use forms of 'evidence' that made sense to them
and were personally meaningful: often quite different
from the types of evidence traditionally valued by clini-
cians (see Appendix 7). The types of criteria and evidence
that patients drew upon to evaluate CAM included the fol-
lowing:
Personal stories
Participants were particularly impressed by the evidence
of personal stories about individuals, including family
members, who had been helped by CAM, often for com-
plaints other than cancer. Biographies of cancer survivors
who had used CAM were regarded as inspirational,
mainly as a model for personal self-help rather than giv-
ing patients belief in a 'cure'. 'She was diagnosed with
breast cancer and ... decided to do something about it and
therefore looked at the total bit not only her mental atti-
tude but her diet her exercise, did everything, meditated,
got in touch with her spirituality did absolutely everything
that she could do to make herself better to rebuild her
immune system and to fight the disease and she was suc-
cessful doing that for twenty years' [age 43, lung cancer in
remission]. Such stories were sourced in books, the inter-
net, leaflets, newspapers and magazines. Some regarded
their own story of survival to date as 'living proof' of the
effectiveness of CAM in combination with conventional
treatment. Other pointed to specific benefits they were
experiencing themselves as sufficient evidence of the effec-
tiveness of their chosen CAM therapy.
History
A common criterion for judging the quality and likely
effectiveness of a CAM therapy was its history. The long
history and enduring popularity of many therapies, for
example herbal remedies and acupuncture, were often
perceived as indicators that they benefited patients. Partic-
ipants were also more inclined to view CAM therapies
positively where there had been a history of using herbal
or other 'natural' products over many generations within
their own family. 'I used to have cod liver oil and malt as
a kid I remember my mother ...but that [supplement] does
help your joints definitely ... there was no proof I don't
think in those days, you just you did that you know, if you
sting yourself, rub a dock leaf on it ...one shouldn't say a
treatment is no good because it hasn't been scientifically
proved'  [age 83, locally advanced prostate cancer].BMC Complementary and Alternative Medicine 2007, 7:25 http://www.biomedcentral.com/1472-6882/7/25
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Plausibility
Participants gave weight to the 'plausibility' of a CAM
therapy as discerned from the information they had gath-
ered and they would only try a therapy that seemed plau-
sible in its mechanism of action. This was very much an
individual judgement and depended on their conceptual-
isation of the particular therapy. For example some had
no belief in the proposed mechanisms of action for acu-
puncture, while others believed it might work via the
nervous system and others believed it worked via the flow
of energy. Where people had a belief in the power of the
mind to effect physiological change, they might be more
inclined to accept therapies that had a 'mind-body'
dimension, for example visualisation, meditation or
hypno-therapy. 'Relaxation, hypnotherapy side of things
which again seemed to be suggesting I mean they're all
different names for the same thing meditation, relaxation,
hypnosis, that the sub-conscious can in fact have quite
profound effects on physiological processes' [age 65, met-
astatic colo-rectal cancer].
Men with a scientific background found it easier to accept
the use of herbal remedies or nutritional supplements, lik-
ening them to allopathic drugs synthesised from natural
products. One scientist was convinced that homeopathy
and acupuncture were plausible, based on evidence he
had read regarding their effectiveness in animals, thus
implying that the effects were more than placebo.
Belief and trust in therapies and their providers
While the majority of participants were using CAM out-
side the NHS, they often expressed a preference for CAM
to be provided via the NHS since this is a trusted source of
care and brought with it a 'stamp of approval'. Some
requested referral to the NHS homeopathic hospital,
which was made easier where they had a prior relation-
ship with a GP with an interest or training in CAM. Such
GPs became a resource for CAM information and referral.
In the absence of NHS endorsement, participants placed
their trust in CAM therapists who had recognised qualifi-
cations and professional registration, or who worked at
well-known centres. 'If they did advertise or there was leaf-
lets in hospitals then at least they could have a maybe a
list of people what have been checked out or that they
know they've done the qualifications and the certificates
are alright and not just someone, you see it so often on the
telly about these fake doctors and everything that just
print their own certificates' [age 43, locally advanced colo-
rectal cancer].
Enduring engagement with a CAM provider, however,
depended more on the personal qualities and experience
of the provider and the therapeutic relationship than on
their formal qualifications.
The same desire for seeking 'approved therapies' was evi-
dent in the way participants sought out information from
the internet. The majority approached the internet with
caution, choosing only to visit medical, professional or
charity websites and steering clear of more commercial
sites. 'I think one of the things you've got to realise is that
whoever's web page you're on is probably promoting their
product ... you can sort of dodge around and look at vari-
ous sites, cross-reference them so, yeh so it is useful' [age
61, prostate cancer in remission].
However, professional authentication was not the only
'quality label' that impressed would-be CAM users. Thera-
pies were seen as legitimate or credible if recommended
by trusted individuals, be they friends, family members or
CAM therapists. Some preferred to trust their own inner
judgement and relied less on external markers of credibil-
ity, describing for example how they acted 'in faith' or
relied on 'gut instinct'. A minority actually valued the
independence of private CAM provision from the NHS,
expressing preference for the 'alternative' philosophical
approaches that under-pin some therapies. Despite this
orientation towards more alternative approaches, these
men too talked about using the internet in a discerning
way and were critical of websites giving treatments that
did not seem credible to them.
Scientific evidence
A common belief among the men studied was that lack of
scientific evidence did not equate with lack of effective-
ness. On this basis, they were prepared to give CAM ther-
apies the benefit of the doubt. Some men, notably those
from a scientific background, reflected on methods used
to study CAM and conventional treatments, identifying
what they saw as the limitations of conventional drug trial
evidence. Their concerns were that such trials report aver-
age rather than individual effects and can under-estimate
long-term safety considerations. Several expressed the
belief that scientific methods were not always appropriate
to evaluate CAM since some therapies pre-dated the
advent of the scientific approach and are based on radi-
cally different philosophies and mechanisms of action.
Whilst recognising that scientific evidence of effectiveness
would be beneficial to attract funding or support for CAM
within NHS, the lack of such evidence did not stop them
personally using CAM. 'I don't think I'm bothered by the
scientific proof about them but I would be willing to try
them, it's maybe the person who's dispensing them I need
to know that they're ... I would prefer to do that than just
try things willy nilly go round trying things, I need to try
things for a reason' [age 56, non-Hodgkin's lymphoma in
remission]. The benefits of some therapies, such as diet and
relaxation, were seen to be common sense, thereby
excluding the need for 'scientific proof'. Scepticism about
the influence of the pharmaceutical companies in pro-BMC Complementary and Alternative Medicine 2007, 7:25 http://www.biomedcentral.com/1472-6882/7/25
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moting certain drugs and marginalising 'alternative' treat-
ments was common.
Discussion
The men in the study said they would welcome more
open discussion and advice about CAM from health pro-
fessionals. In contrast, their experience reveals that little
CAM information was available to them via the NHS and
they found it difficult to broach the subject of CAM with
health professionals. Men felt that the onus was on them,
the patients, to inform themselves and make their own
decisions about whether or not to use CAM and some felt
uncomfortable about taking on such a pro-active role.
This situation may not, however, be unique to CAM. Our
data support earlier findings that doctors tend to give
information about illness and treatment only to patients
who actively request and seek it [18] thus reinforcing the
pro-active role required of patients.
Against this background of a perceived reluctance on the
part of doctors to give out additional information will-
ingly, patients are likely to have a particularly difficult
time finding out about CAM, a subject about which doc-
tors themselves may have limited knowledge or interest or
about which they may hold views which are at variance
with those of their patients. As reported elsewhere, this
may impact negatively on patients' ability to cope with
their cancer, since those men who did successfully access
CAM regarded it as a crucial component of their support-
ive care [16].
Many participants did feel comfortable with a pro-active
role as a CAM information seeker and indeed, previous
studies show how CAM users frequently benefit from the
sense of personal 'empowerment' that accessing CAM can
provide, with its opportunities for consumer choice and
its emphasis on self-care [19,20]. Our study suggests,
however, that there are also a group of patients who prefer
a more 'passive' role and would prefer their clinician to
provide advice or make decisions for them. Amongst the
participants characterised as more 'passive', many were in
fact open to and welcomed the provision of information
and advice about CAM from trusted individuals. Such
individuals at present tend to consist of partners, family
and friends, who have been shown to play a significant
part in influencing decisions about CAM use in this and
other populations of cancer patients [21]. Most partici-
pants in the present study clearly saw health professionals
as trusted individuals and so, equipped with appropriate
information, they too could play a significant role in help-
ing patients make informed choices about CAM use. The
growing number of specialist nurses in oncology com-
prises a professional group that might feasibly take on this
role. Another option might be for such a role to be taken
on within primary care, either by doctors or nurses, espe-
cially since the registration and follow up of cancer
patients are targets for GPs in the new contract [22,23].
Patient choice, participation in decision-making and the
'expert patient' [24] are all concepts endorsed by current
NHS policy, yet studies such as this indicate that the trans-
lation of concepts of choice from policy into practice is far
from complete. One cause of this may be a potential ten-
sion between the evidence-based medicine and patient
choice agendas that both underpin NHS policy, as has
been recently highlighted in a study of asthma patients
use of complementary therapies [25]. The present find-
ings also contribute to the broader debate about the
changing nature of the doctor/patient relationship from
the traditional 'paternalistic' model to the alternative
models of 'shared decision-making' or the 'consumerist'
approach where patients take greater responsibility for
informing themselves and being involved in treatment
decisions. It may be that the balance has gone too far
towards placing the onus on patients to be informed – a
finding that concords with studies in other areas of patient
care [26]. Despite a recent policy emphasis on encourag-
ing patient choice [27], too much choice can be confusing
for some patients. With regards to CAM, patients may
need guidance and help in making decisions and NHS
professionals could develop a stronger role in helping
patients to make appropriate choices about CAM use. This
is graphically illustrated in this quote: 'Imagine being in a
fast flowing river and the guy on the bank has got half a
dozen different aids to help you and he's shouting to you
which one do you want? You know, I don't care which one
it is as long as it, you know don't you know which one to
throw '[age 61, prostate cancer in remission].
A recent study of health information seeking (not specifi-
cally about CAM) showed that women with breast cancer
adopt similar strategies to the men in this study in order
to inform themselves about their illness and its treatment
[7]. They, too, fell into distinct groups, some taking an
active approach to information gathering and others pre-
ferring a more passive approach. The women, like the men
in the present study, also stated a preference for tradi-
tional print media rather than electronic media as a form
of communication. In view of concerns about the lack of
regulation of e-information [28,29], it is important to
note that, in both studies, information picked up from the
popular press or from books written by cancer survivors,
was used in CAM decision-making equally often as was
the internet. Another study of cancer patients in Hawaii
who used CAM showed that participants were drawing on
a similar range of information resources to those in the
present study [8], but preferences for different modalities
of health information varied according to ethnic group
and educational level. The implications of these findings
are twofold: first, the over-emphasis on regulation ofBMC Complementary and Alternative Medicine 2007, 7:25 http://www.biomedcentral.com/1472-6882/7/25
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internet information overlooks the fact that much infor-
mation derived from other sources may be equally anec-
dotal or biased, and second, the assumption that the
internet is the main source of information for patients
may not necessarily be true.
One potential barrier to improving communication about
CAM between patients and health professionals is likely
to be the different standards of evidence used by patients
and doctors in evaluating the effectiveness and safety of
CAM therapies. Patients in the present study used a range
of criteria to evaluate CAM therapies, usually favouring
experiential evidence (patients' stories), rather than scien-
tific evidence of effectiveness. This is similar to the find-
ings of a Canadian study [30] and is in contrast to the
regular calls for 'more scientific evidence' for CAM from
members of the medical community.
Patients' decisions to use CAM may appear 'irrational' to
clinicians, based as they are on limited scientific evidence,
but patients are making meaningful and 'rational' deci-
sions within their own frame of reference and value sys-
tem. Debates about patients' apparently 'irrational'
treatment choices do, however, pre-date the recent rise in
popularity of CAM, and have tended to focus on the high
rates of 'non-compliance' with or poor 'adherence' to con-
ventional medical treatments [31]. A recent qualitative
study of cancer patients' decisions to accept or refuse con-
ventional treatment has highlighted the differing perspec-
tives of doctor and patient [32]. In a similar way to the
study reported here, doctors tended to apply a 'goal-ori-
ented' rationality, contrasting with the 'value-oriented'
rationality of patients. The authors concluded that clini-
cians' acceptance and understanding of an apparently
'irrational' decision is essential to establishing a better
doctor-patient relationship in which the patient feels
understood, respected and free to decide.
Conclusion
This study reveals that male cancer patients who wish to
use CAM would generally prefer to access information
about CAM via the NHS. This concords with the recom-
mendation of the NICE Guidelines for Supportive and
Palliative Care that 'as a minimum, high quality informa-
tion should be made available to patients about comple-
mentary therapies and services' [33]. For men in this
study, finding out about CAM was part of a broader strat-
egy of informing themselves about their condition and its
treatment. Because of the distressing and life-threatening
nature of their illness, cancer patients may be particularly
susceptible to picking up information about their condi-
tion and how they might improve it. This could be used to
positive benefit by the NHS in developing a strategy for
the delivery of high quality CAM information and advice.
The level and type of information would need to be
graded in order to respect the needs of those who are
likely to feel burdened by additional choices.
Men in this study were discerning in their evaluation of
CAM information, offered rationales for their choices and
often adopted a 'consumerist' approach to CAM treatment
options. While health professionals often express con-
cerns about patients being 'duped' by CAM providers
offering a 'cure' at great expense, only a minority of men
in this study chose to try a range of potentially 'curative'
treatments at considerable financial cost. Information
about such treatments was obtained through networks of
acquaintances and sometimes through the internet. Web-
site regulation and kite-marking is unlikely to deter these
patients who wish to look beyond the boundaries of con-
ventional medicine and choose alternative treatments pre-
cisely because they are outside the conventional
healthcare system.
Our findings concord with those from a qualitative study
in the USA which stressed the importance of finding a
'common ground for an open discussion in which physi-
cians consider that scientific evidence is not all that counts
in the life of an individual facing a serious disease' [4].
Without such open discussion, cancer patients using CAM
may find themselves at odds with health professionals
regarding their choices, or at least they may experience an
indifferent response. This may have future consequences
for care as it may discourage further disclosure of CAM
use. The challenge for clinicians is to engage in open dis-
cussion with patients about CAM, to foster an environ-
ment of mutual trust that is likely to lead to better
disclosure of CAM use rather than to perpetuate an atmos-
phere that may encourage covert, undisclosed use of
CAM.
Strengths and limitations of the study
Qualitative studies of information seeking such as this are
less common than large-scale surveys and provide an
opportunity for issues to be explored in more depth. This
study also breaks new ground by focusing on men with a
range of cancer types, who have been the focus of much
less qualitative research in the field of CAM and cancer
than women. This study aims to redress that balance. Men
may formerly have been overlooked since surveys show
that they use CAM less than women [34], they seek less
information about CAM from a national cancer informa-
tion service [12] and use the internet less than women for
health information seeking [35]. The strategies that men
adopt to access CAM information are therefore worthy of
a specific study such as this one. A future study might
directly address possible gender differences in accessing
and evaluating CAM information.BMC Complementary and Alternative Medicine 2007, 7:25 http://www.biomedcentral.com/1472-6882/7/25
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As the study is qualitative, the findings are not necessarily
representative of the views of all cancer patients but they
may not be atypical and may well be transferable to cancer
patients in similar settings in other parts of the UK. Care
was taken to recruit patients across a wide range of ages,
cancer types and disease stages, who came from a range of
setting both within and outside the NHS and who are
likely to present a wide spectrum of views and experi-
ences. There were no participants from ethnic minority
groups. The sample also comprised a majority of men
with professional occupations, a finding typical of studies
of CAM use. These findings add to the growing literature
on health information seeking and make a unique contri-
bution by focussing specifically on patients' search for and
evaluation of CAM information.
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Appendix 1: Glossary of 'complementary and 
alternative' treatments used in this study
Nutrition:  Many followed a wheat-free, dairy-free,
organic, vegan programme with nutritional supplements
including vitamins, fish oils and selenium. Advice taken
from a nutritionist, books or, occasionally, the internet.
Following advice, some supplements were withheld dur-
ing chemotherapy. A minority had experimented with a
range of extreme 'anti-cancer' diets such as the Gerson
Institute programme.
'Mind – body therapies': Healing, hypno-therapy, visual-
isation, relaxation, reiki, t'ai chi, qi gong and movement
therapy.
Homeopathy: remedies prescribed by the consultant at
the homeopathic clinic.
Psychological therapies: Individual and group counsel-
ling, positive affirmations, 'journeying' (exploring your
soul journey using shamanic techniques), on-line peer
support and the 'Health Creation Kit' (a self-help 'Cancer
lifeline kit' developed by an Integrated Cancer Consult-
ant).
Physical and 'hands-on' therapies: Acupuncture, mas-
sage, shiatsu, reflexology, aromatherapy, cranio-sacral
therapy, kinesiology and exercise therapy.
Herbal remedies
Iscador: fermented extract of mistletoe used to boost the
immune system and provide anti-tumour properties.
Bach Flower remedies: diluted essences of flowers to re-
balance the body's energy.
Gingko biloba: leaf extract used to improve blood circu-
lation.
Saw palmetto: palm berry extract used for prostate symp-
toms.
Essiac: herbal tea containing burdock root, sheep sorrel,
slippery elm and rhubarb used to treat cancer.
Green tea: used in China for 4,000 years to inhibit cancer
cell growth.
Apricot kernels: a natural source of vitamin B17 used as
an anti-cancer agent.
Carctol: an Indian ayurvedic compound used to treat can-
cer.
Pycnogenol: pine bark extract used as an anti-oxidant.
Noni juice: tropical plant extract used to support the
immune system.
Other 'alternative' therapies'
Cyto-luminescent therapy: whole body irradiation with
light of a specific wavelength to selectively damage and
eliminate tumour cells.
Vitamin B17: often given as an infusion and claimed to be
anti-neoplastic.
Psychic surgery: an operation is performed with no scal-
pels or instruments. Body parts and masses and removed
and no scar is left.
Rife: a treatment invented by Royal Rife in the 1930s to
cure cancer using electronic frequencies.
Parasite cleansing: a variety of herbs used to cleanse the
body of parasites.
Colloidal silver: Manufactured from silver, this treatment
claims to be antiviral, antifungal and antibacterial.BMC Complementary and Alternative Medicine 2007, 7:25 http://www.biomedcentral.com/1472-6882/7/25
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Appendix 2: Information provision and 
communication about CAM with health 
professionals
Lack of interest in CAM shown by clinicians
'Q: Do the oncologists know that you're taking essiac?
They're not interested. They're not remotely interested in
what I'm taking or not taking ... I've told them and they
say mmm mmm yes they're not interested in anything'
[age 42, metastatic thymic cancer]
Patients' desire for NHS to offer CAM information
'I've mentioned it to the doctors but they don't seem very
forthcoming, not on the National Health anyway, they
don't seem to want to .... Really I would go and have a go
if someone recommended something, ... there should be
leaflets in doctor's surgeries or hospitals so you can look
at it, like in the chemotherapy if there was leaflets on the
walls saying why don't you try this and that just to help
you get through ... I'm sure there must be things that could
probably help with the side effects of chemotherapy
because there's a lot of them to be honest, lots of things
you can get' [age 43, locally advanced colo-rectal cancer]
'Down at the oncology centre they don't really mention it
[the homeopathic hospital] but they can give you stuff
what can help your body and help your immune system
that's what you need the nurse to say' [age 43, metastatic
colo-rectal cancer]
Appendix 3: The role of family and friends
Female relatives/partners
'My ex-girlfriend is a shiatsu practitioner .... So I spoke to
her about it, she plugged me with books which is her
thing, her thing's books, information, information, infor-
mation she loves all that and she reads and reads fero-
ciously and ah I'm the opposite you know I want to kind
of I want to get information personally' [age 47, early stage
leukaemia]
Friends
'We were looking for a doctor and we just got talking to
one of our friends who mentioned him (GP homeopath),
we went to see him and he was such a lovely man and he
had personality, you had confidence in him really, I
wasn't worried if he used alternative medicines, 'cos some
doctors just give you a packet of pills and you're gone' [age
54, prostate cancer in remission]
Appendix 4: The role of the internet
Discerning use of the internet
'Once I found one [website] that I was getting quite a lot
of information from I didn't go much farther than that ...
I didn't have, I'm not one of those that goes to every site'
[age 58, metastatic prostate cancer]
'I've always been a little put off by the sort of web-sites that
don't seem to be very based in logic or evidence ... I want
to be presented with some evidence that something works
other than just personal comments' [age 42, metastatic
thymic cancer]
Internet to follow up suggestions
'People have mentioned oh have you tried this, or have
you tried this ... so then I use the internet to look up these
things that people mention .. so I actually found the inter-
net in that sense brilliant' [age 43, recurrent bone cancer]
Non-use of the internet
'I don't [use the internet] because the information's sup-
posed to be given to you at the sharp end isn't it, the hos-
pital .... Well I've got a computer, but I don't particularly
chase the internet .... I'm not particularly computer ori-
ented I'm surrounded by computers but I'm not the kind
to want to know things about it' [age 57, metastatic colo-
rectal cancer]
Appendix 5: 'Traditional' sources of information 
used by participants
Books and articles
'General books, things in the newspapers, I did read a few
things when we first went to [homeopathic GP]. I did read
a few articles. I went to the library to read a few things
about alternative medicines .... You have to be sceptical at
first .... But I have done you know I've read a few books
now. It did make me think a bit differently' [age 54, pros-
tate cancer in remission]
Leaflets
'I picked up a sheet from their church [Spiritualist] and
there was an advertisement in there for a Finnish bark
product .... And when I was in the newspaper I used to get
a lot of books to review and one of them was a book by
another journalist who had gone to South America to
investigate these wonder cures .... And when I went to the
[private cancer charity] I asked I wanted a book about the
mental attitude' [age 79, metastatic prostate cancer]
Magazines
'There are these buildings which offer complementary
support and therapies [to cancer patients] and so they're
attached to an oncology department.
Q: So how did you find out about them?
Um, when I was at the [GP practice], there was a, I was
reading a copy of Vogue or something called Marie, I
think it was Vogue, ah from last year and they had a big
article about it' [age 41, metastatic lung cancer]BMC Complementary and Alternative Medicine 2007, 7:25 http://www.biomedcentral.com/1472-6882/7/25
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Appendix 6: Patients as pro-active seekers or 
passive recipients of information
Pro-active by choice
'I suppose it's down to the individual to sort of do their
own research and make up their own minds about what
they want to do' [age 60, locally advanced lung cancer]
Passive by choice
'He [oncologist] just, it was very caring actually you know
he knew that we weren't ones to, we're quite passive peo-
ple actually in a sense, me and my wife, we're not ones
which want to, you know, so many questions we want all
the answers, we just knew we want the information there,
we could just go away and digest it' [age 49, metastatic colo-
rectal cancer]
Appendix 7: Patients' criteria for evaluating 
CAM
Historical use of CAM
'No because if they have been efficacious for centuries
whilst there might be an interest in trying to measure
them scientifically, like Chinese techniques ... there is no
doubt it works which is an amazing thing ... the history of
acupuncture it goes back over three thousand years' [age
73, prostate cancer in remission]
Plausibility
'Yes, and ...um... [pause] they do kind of holding hands
business and yes ... I don't go for that at all [laughing] you
know, and ...um... I don't think you can cure cancer just
by saying 'I haven't got it', you know it ..um ...I don't think
that would work .. no ...um... anything that smacks of
kind of mysticism or spiritualism or that it's to me no it's
a waste of time I just cannot accept that' [age 83, locally
advanced prostate cancer]
Belief and trust in therapies and their providers
'I was once invited to go to the cranio-sacral therapist ....
My wife knows him .... I found it scary, the techniques,
putting pressure points on the skull and you, the patient,
don't know what's happening. There was a 'guru atmos-
phere' to this guy. I couldn't take it'
'Things like acupuncture I wouldn't try .... You should see
the charts! It depends how desperate you were, for exam-
ple if the clinical system had given up on you. I wouldn't
touch reflexology with a barge-pole if it wasn't for my
daughter doing it. But I wouldn't go along with the medics
who poo-poo alternatives .... But the way out stuff I would
need proof, or a person to recommend it who I could
trust, like the person who recommended Dr L. A certificate
on the wall is not enough' [age 66, prostate cancer in remis-
sion]
Scientific evidence
'If you wait until something is absolutely tried and tested
and guaranteed to work but in fact nothing is guaranteed
to work ... Um you know it all depends on the individual
and I think you know one thing that does convince me is
you know if one person is able to recover or have a full
remission from cancer without medical treatment, that
proves the body can have the capacity to do it' [P34 age 53,
locally advanced non-Hodgkin's lymphoma]
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